Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Capital Expenditures: 2024

Historic Capital Expenditures for CG Oncology (CGON) over the last 1 years, with Dec 2024 value amounting to $234,000.

  • CG Oncology's Capital Expenditures rose 9800.00% to $97,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $336,000, marking a year-over-year change of. This contributed to the annual value of $234,000 for FY2024, which is N/A change from last year.
  • As of FY2024, CG Oncology's Capital Expenditures stood at $234,000.
  • In the past 5 years, CG Oncology's Capital Expenditures ranged from a high of $234,000 in FY2024 and a low of $234,000 during FY2024.
  • Over the past 1 years, CG Oncology's median Capital Expenditures value was $234,000 (recorded in 2024), while the average stood at $234,000.